7
Outcomes in Patients Without Diabetes at Baseline
Unadjusted Relative Risk with 95% CI
Outcome New-Onset Diabetes
CAS n = 8101 No. (%)
569 (7.03)
NCAS n = 8082 No. (%)
2020年10月2日
Systolic Diastolic
0
-5
-10
Байду номын сангаас
-10.0 -10.2
p = 0.26
-15
-20 -18.7 -19.0 p = 0.41
4
Overall BP Control at 24 Months
% Patients
--INVEST--
-- ALLHAT -- -- LIFE --
2020年10月2日
2
INVEST
• Design
– Prospective, randomized, open trial with blinded endpoint evaluation (PROBE) to assess outcomes (death, MI, stroke) in hypertensive CAD patients treated with either a calcium antagonist based (verapamil SR) or noncalcium antagonist based (atenolol) treatment strategy
100
RR = 0.98, 95% CI 0.90, 1.06
95